Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.
Gerdes S, Staubach P, Dirschka T, Wetzel D, Weirich O, Niesmann J, da Mota R, Rothhaar A, Ardabili M, Vlasitz G, Feldwisch J, Osterling Koskinen L, Ohlman S, Peloso PM, Brun NC, Frejd FY. Gerdes S, et al. Among authors: weirich o. Br J Dermatol. 2023 Sep 15;189(4):381-391. doi: 10.1093/bjd/ljad186. Br J Dermatol. 2023. PMID: 37697683 Clinical Trial.
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE).
Pinter A, Hoffmann M, Reich K, Augustin M, Kaplan K, Gudjónsdóttir SD, Delvin T, Mrowietz U; CHANGE investigator group. Pinter A, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):701-711. doi: 10.1111/jdv.16932. Epub 2020 Dec 23. J Eur Acad Dermatol Venereol. 2021. PMID: 32939860 Clinical Trial.
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial.
Picardo M, Cardinali C, La Placa M, Lewartowska-Białek A, Lora V, Micali G, Montisci R, Morbelli L, Nova A, Parodi A, Reich A, Sebastian M, Turek-Urasińska K, Weirich O, Zdybski J, Zouboulis CC; GEDACNE Study Group. Picardo M, et al. Among authors: weirich o. Br J Dermatol. 2022 Oct;187(4):507-514. doi: 10.1111/bjd.21663. Epub 2022 Jun 23. Br J Dermatol. 2022. PMID: 35553043 Free PMC article. Clinical Trial.
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Long-Term Stability of Short Circuits in Deep Brain Stimulation.
Allert N, Jusciute E, Weirich O, Daryaeitabar M, Nolden BM, Karbe H. Allert N, et al. Among authors: weirich o. Neuromodulation. 2018 Aug;21(6):562-567. doi: 10.1111/ner.12709. Epub 2017 Oct 24. Neuromodulation. 2018. PMID: 29064606